---
author: mike
pubDatetime: 2024-05-01 13:52:57.786000
modDatetime: 
title: Q124 GEHC earnings
slug: q124-gehc-earnings
featured: false
ogImage: /assets/images/250_250.png
tags:
  - transcripts
  - earnings
  - healthcare
description: Earnings summary for GE HealthCare
---
### Earnings Results

- **Revenue**: $4.6 billion in Q1 2024, approximately flat organically year-over-year.
- **Organic Orders**: Increased 1% year-over-year, primarily driven by strength in the U.S.
- **Book-to-Bill**: Total company book-to-bill of 1.03x, up from 1.01x last year.
- **Backlog**: Exited the first quarter with a healthy backlog of $18.7 billion.
- **Adjusted EBIT Margin**: 14.7%, up 50 basis points year-over-year.
- **Adjusted EPS**: $0.90, up 6% year-over-year.
- **Free Cash Flow**: Generated $274 million, driven by improved working capital.

### Future Guidance

- **2024 Full Year Guidance**: Reaffirmed, expecting modest sequential improvement in Q2 organic sales growth and adjusted EBIT margin.
- **Revenue Growth**: Stronger in the second half of the year.
- **New Product Launches**: Expected to accelerate growth in ultrasound.
- **Expected Growth Areas**: Imaging, supported by healthy backlog and large order funnel; continuing growth in PDx business; improvement in PCS backlog fulfillment challenges by mid-year.

### Trends, Market Conditions, Sentiment

- **Capital Investment**: Positive sentiment among customers about capital investment and market normalization, particularly in the United States.
- **Healthcare Demand**: Strong global procedure environment expected to continue, with a more connected, efficient, and patient-centric healthcare market.
- **Innovation and Investment**: Continued investment in innovation, including partnerships and strategic initiatives, aimed at solving evolving customer and patient needs.
- **Market Challenges**: Fulfillment delays and prior year comparisons as challenges; anticorruption impacts and stimulus considerations in China.
- **Product and Service Growth**: Good growth opportunities identified in both product and service sectors, supported by a growing installed base.

### Notable Quotes

- "We've made good progress against our key priorities for 2024. Healthy backlog, orders growth and positive book-to-bill position us for accelerated growth for the rest of the year." - Peter Arduini, President and CEO.
- "Our strategic initiatives and trusted partnerships are taking hold and position us well for a future where health care is more connected, efficient and patient-centric." - Peter Arduini.
- "We're executing on significant capacity investments to strengthen the security of supply for our customers and to deliver on our patients' needs." - James Saccaro, Vice President and CFO.
- "We're excited about recent product introductions across our segments to address customer challenges and improve patient outcomes." - Peter Arduini.
